trial
as of 2026-07-01Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia
NCTId NCT02011750
at a glance
Phase 4 · Completed
Enrollment 109 (actual)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2017-10-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
109 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2013-04-01
Primary completion
2017-10-30
Eligibility
ALL · 18 Years · 50 Years
Interventions & indications
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
Mansoura UniversityCollaborator
Stanley Medical Research InstituteCollaborator
Investigators
1
Hader Mansour, MDPrincipal Investigator
Sites
1 total
Al Mansurah, Egypt
Facts & assertions
4 sourced
Enrollment
109
Phase
PHASE4
Primary Completion Date
2017-10-30
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator
person